In the present study, we obtained data that demonstrate an approach to improving the diagnosis, assessment of antitumor immune system, and monitoring the effectiveness of chemotherapy in SCLC based on the dynamic control of the content of cytotoxic CD3+CD8+ T-lymphocytes, CSCs, and CTCs. The gene discussed is CD8A; the disease is small cell lung carcinoma.